Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 3-(phenyl)-N-(4-phenoxybenzyl)-1,2,4-oxadiazole-5-carboxamide compounds for the management of CFTR protein mediated diseases

3-(phenyl)-N-(4-phenoxybenzyl)-1,2,4-oxadiazole-5-carboxamide compounds for the management of CFTR protein mediated diseases

US Patent 11020379 · Granted Jun 1, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

3-(phenyl)-N-(4-phenoxybenzyl)-1,2,4-oxadiazole-5-carboxamide compounds for the 2023
3-(phenyl)-N-(4-phenoxybenzyl)-1,2,4-oxadiazole-5-carboxamide compounds for the 2023
2-amino-N'-benzylideneacetohydrazides and derivatives for the management of CFTR2021
2-amino-N'-benzylideneacetohydrazides and derivatives for the management of CFTR2021
Adjusting device for a vehicle seat2021
2-amino-N′-benzylideneacetohydrazides and derivatives for the management of CFTR2020
2-amino-N′-benzylideneacetohydrazides and derivatives for the management of CFTR2020
3-(phenyl)-N-(4-phenoxybenzyl)-1,2,4-oxadiazole-5-carboxamide compounds for the 2019
3-(phenyl)-N-(4-phenoxybenzyl)-1,2,4-oxadiazole-5-carboxamide compounds for the 2019
ABC transporter ligand GATX12012